US 7,320,999 B2
Dimethyl fumarate for the treatment of multiple sclerosis
Rajendra Kumar Joshi, Zürich (Switzerland); and Hans-Peter Strebel, Muri (Switzerland)
Assigned to Fumapharm AG, Luzern (Switzerland)
Filed on Jul. 17, 2002, as Appl. No. 10/197,077.
Application 10/197077 is a division of application No. 09/831620, granted, now 6,509,376, previously published as PCT/EP99/08215, filed on Oct. 29, 1999.
Claims priority of application No. 198 53 487 (DE), filed on Nov. 19, 1998.
Prior Publication US 2003/0018072 A1, Jan. 23, 2003
Int. Cl. A61K 31/22 (2006.01)
U.S. Cl. 514—549 18 Claims
 
1. A method of treating multiple sclerosis comprising treating a patient in need of treatment for multiple sclerosis with an amount of a pharmaceutical preparation effective for treating said multiple sclerosis, wherein the only active ingredient for the treatment of multiple sclerosis present in said pharmaceutical preparation is dimethyl fumarate.